Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial

Biochemical verification of tobacco use and cessation

Neal L. Benowitz, Peyton Jacob, Karen Ahijevych et al. · Nicotine & Tobacco Research · 2002 · 1.8K citations · Full text

Public Health, Biochemistry, Tobacco Control +11

Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Douglas E. Jorenby · JAMA · 2006 · 1.7K citations

Medicine, Pharmacology, Pharmacotherapy +17

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial

Robert M. Anthenelli, Neal L. Benowitz, Robert West et al. · The Lancet · 2016 · 1.2K citations · Full text

Medicine, Pharmacology, Psychiatry +17

Cigarette Smoking Prevalence Among Adults With HIV Compared With the General Adult Population in the United States

Rennatus Mdodo, Emma L. Frazier, Shanta R. Dube et al. · Annals of Internal Medicine · 2015 · 450 citations

Public Health, Health Sciences, Population Health Sciences +17

Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation

Cheryl Oncken · Archives of Internal Medicine · 2006 · 379 citations

Medicine, Obstetrics, Pharmacology +12